Eli Lilly and Co. (LLY) announced positive results from the Phase 3 BRUIN CLL-322 clinical trial evaluating Jaypirca (pirtobrutinib), a non-covalent Bruton tyrosine kinase (BTK) inhibitor, in combination with venetoclax and rituximab versus venetoclax and rituximab alone in patients with relapsed or...
Air Canada (AC.TO) announced that it has reached a tentative collective agreement with the International Association of Machinists and Aerospace Workers (IAMAW). The agreement covers more than 11,000 employees working across Maintenance, Cabin Services, Airport Airside Operations, Cargo, Finance, and...
Genmab A/S (GMAB) reported positive findings from two clinical studies evaluating epcoritamab in elderly patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) who are not eligible for anthracycline-based chemotherapy. In the Phase 2 EPCORE DLBCL-3 trial, fixed-duration epcoritamab monotherapy...
The Antitrust Division of the U.S. Department of Justice announced that it closed its investigation into the proposed acquisition of Warner Bros. Discovery (WBD) by Paramount Skydance Corporation (PSKY). After completing its analysis, the Division determined that the transaction is not likely to result...
Target Corp. (TGT) announced the results of its 2026 Annual Meeting of Shareholders held on June 10, 2026. Shareholders rejected three proposals, including a request for a policy requiring the Board Chair to be independent, a report on the presence of pesticides in Target's private label brands, and...
JBS USA announced plans to close two facilities located in Pennsylvania and Tennessee as part of targeted changes aimed at strengthening its operations for the future. The company emphasized its commitment to supporting employees impacted by the decision. The closures include the beef production facility...
Roche (RHHBY) announced that the VENTANA PTEN (SP218) RxDx Assay has become the first immunohistochemistry (IHC) companion diagnostic test to receive approval from the U.S. Food and Drug Administration (FDA) for determining PTEN protein loss, also known as PTEN deficiency, in tumours of patients with...
OpenText (OTEX, OTEX.TO) has announced a 105 million euros investment that will create 400 new jobs across its sites in Ireland over the next three years. This commitment doubles the company's investment in the country and will significantly expand its capabilities in agentic AI, cybersecurity, sovereign...
AstraZeneca's (AZN,AZN.L,ZEG.DE,AZN.ST) Truqap (capivasertib), in combination with abiraterone and prednisone, has been approved in the US as the first and only targeted treatment for adult patients with PTEN-deficient metastatic androgen pathway modulation-naïve or -sensitive (mAPMN/S) prostate cancer—previously...
Sanofi (SNY) announced that the U.S. Food and Drug Administration has granted accelerated approval to Tzield (teplizumab-mzwv) for delaying the decline in endogenous insulin production in children aged 8 to 17 years recently diagnosed with stage 3 type 1 diabetes (T1D). Tzield is not effective as a disease-modifying...
Much-awaited shares of Space Exploration Technologies Corp. (SPCX) have finally begun trading on the Nasdaq at $135 per share following the company's initial public offering (IPO) of 555.56 million Class A common shares, priced at $135 each. However, a recent Wall Street Journal report suggests that...
Dutch bank ING Groep N.V.(ING, INGA.AS, INN1.DE, 1INGA.MI) announced on Friday that it has cut its stake in Thailand's TMBThanachart Bank or TTB to 19.5 percent from 23.1 percent by participating in the lender's share buyback program. The company received gross proceeds of about 243 million euros...
Friday, Jazz Pharmaceuticals plc (JAZZ) announced that the Phase 3 LAGOON trial, evaluating Zepzelca (lurbinectedin) in patients with relapsed metastatic small cell lung cancer, did not meet its primary endpoint of overall survival. The trial, conducted by , comprised of three arms: one arm to receive...
51Talk Online Education Group (COE) reported a first quarter net loss attributable to ordinary shareholders of $2.3 million, compared with a net loss of $1.7 million, a year ago. Net loss per share was $0.01, compared with a loss of $0.005. Net loss per ADS was $0.39, compared with a loss of $0.29. Excluding...
Expensify, Inc. (EXFY), an expense management software company, on Friday announced the final results of its modified Dutch auction tender offer to purchase up to $25 million of its Class A common stock. The company accepted 6,053,023 shares for purchase at $1.20 per share for approximately $7.3 million....
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.